BMB Reports : eISSN 1976-670X

Cited by CrossRef (14)

  1. Jiayin Zhao, Yongtao He, Yufei Duan, Yuanyuan Ma, Hongtian Dong, Xiaoshuang Zhang, Rong Fang, Yunhe Zhang, Mei Yu, Fang Huang. HDAC6 Deficiency Has Moderate Effects on Behaviors and Parkinson’s Disease Pathology in Mice. IJMS 2023;24:9975
    https://doi.org/10.3390/ijms24129975
  2. Bo Han, Xiu Gu, Mengfei Wang, Huihao Wang, Niubing Sun, Xuezhi Yang, Qingwei Zhang. Design, synthesis and neuroprotective biological evaluation of novel HDAC6 inhibitors incorporating benzothiadiazinyl systems as cap groups. Chem Biol Drug Des 2024;103
    https://doi.org/10.1111/cbdd.14556
  3. Andrew Speidell, Noman Bin Abid, Hiroko Yano. Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington’s Disease: Mechanisms and Potential Therapeutics. Biomedicines 2023;11:2275
    https://doi.org/10.3390/biomedicines11082275
  4. Balapal S Basavarajappa, Shivakumar Subbanna. Unlocking the Epigenetic Symphony: Histone Acetylation’s Impact on Neurobehavioral Change in Neurodegenerative Disorders. Epigenomics 2024;16:331
    https://doi.org/10.2217/epi-2023-0428
  5. Jonathan van Eyll, Robert Prior, Sylvain Celanire, Ludo Van Den Bosch, Frederik Rombouts. Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders. Expert Opinion on Therapeutic Targets 2024;28:719
    https://doi.org/10.1080/14728222.2024.2404571
  6. Tadahiro Numakawa, Ryutaro Kajihara. The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders. Molecules 2025;30:848
    https://doi.org/10.3390/molecules30040848
  7. Kianoush Ghiasvand, Mehdi Amirfazli, Parvaneh Moghimi, Fatemeh Safari, Mohammad Ali Takhshid. The role of neuron-like cell lines and primary neuron cell models in unraveling the complexity of neurodegenerative diseases: a comprehensive review. Mol Biol Rep 2024;51
    https://doi.org/10.1007/s11033-024-09964-x
  8. Yulia Aleksandrova, Margarita Neganova. Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases. IJMS 2023;24:14766
    https://doi.org/10.3390/ijms241914766
  9. Somaya Y. Ibrahim, Jayden Carter, Rushita A. Bagchi. Histone Deacetylases in Metabolism: the Known and the Unexplored. Physiology 2025;40:000
    https://doi.org/10.1152/physiol.00044.2024
  10. Chunyan Chen, Zhuye Xia, Min Zhang, Yunshan Cao, Qingling Chen, Qinglian Cao, Xiang Li, Fan Jiang. Molecular mechanism of HDAC6-mediated pyroptosis in neurological function recovery after cardiopulmonary resuscitation in rats. Brain Research 2024;1843:149121
    https://doi.org/10.1016/j.brainres.2024.149121
  11. Dahee Choi, Ann-Yae Na, Seok-Won Jeoung, Yun-Hee Choi, Nayoon Park, Hyun-Sun Park, Hyuk-Kwon Kwon, Hyun-Shik Lee, Dong-Hyung Cho, Dong Hyun Kim, Hong-Yeoul Ryu. Histone H3 lysine 9 tri-methylation is associated with pterygium. BMC Ophthalmol 2025;25
    https://doi.org/10.1186/s12886-025-03939-7
  12. Jingjing Pu, Amit Sharma, Jian Hou, Ingo GH Schmidt-Wolf. Histone Deacetylase 6: At the Interface of Cancer and Neurodegeneration. Epigenomics 2023;15:1195
    https://doi.org/10.2217/epi-2023-0373
  13. Ziwei Cai, Congmin Liang, Kailun Huang, Jiankun Luo, Renjian Lu, Yixi Lai, Dongyan Zheng, Zhuomiao Lin, Jiahong Zhong, Juanxiu Dai, Jiewen Huang, He Zhang, Jialong Chen. Curcumin prevents neurodegeneration by blocking HDAC6–NLRP3 pathway-dependent neuroinflammation in Parkinson’s disease. International Immunopharmacology 2025;146:113928
    https://doi.org/10.1016/j.intimp.2024.113928
  14. David W. Christianson. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases. Acc. Chem. Res. 2024;57:1135
    https://doi.org/10.1021/acs.accounts.3c00801